Your genes encode drug-metabolizing enzymes, drug targets, and other proteins related to the action of drugs. Pharmacogenomics studies variation in the expression of disease-relevant genes and variable responses to certain drugs in order to develop new treatment pathways. Some drugs have desired effects on some people but not on others.Genetics plays important role here. We rely on scientific evidence from renowned publications for this genetic study.

How does pharmacogenomics testing benefit us?

Currently, adverse drug reactions lead to significant morbidity and mortality in patients, often resulting in increased healthcare costs. Variations in drug response may be due to exogenous factors—for example, diet, consumption of coffee, tobacco, alcohol, other medicines, etc. But also endogenous factors such as age, gender and, importantly, genetics. It must be absorbed, metabolised, transported, degraded and excreted. At any of these steps, a variation in the sequence of a gene can interact with the drug and generate a different response than expected.

Our pharmacogenomics test helps to identify our genetic predisposition and individual response to drugs. The results of this report can be used as a aid in the clinical decision-making process and reduce the cost and time associated with a trial-and-error treatment.